IP Library Granted Patent US 7,037,713
Granted Patent B2
US 7,037,713 · App. 10/074,302 · Granted May 2, 2006

High-efficiency wild-type-free AAV helper functions

Assignee: Avigen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,037,713
App. No.
10/074,302
Granted
May 2, 2006
Kind
B2
Abstract

The present invention provides methods and compositions for producing high titer, wild-type-free preparations of recombinant AAV (“rAAV”) virions. The compositions of the present invention include novel nucleic acids encoding AAV helper functions and AAV helper function vectors. The present invention also includes host cells transfected by the claimed nucleic acids, methods of using the claimed vectors, and rAAV virions produced by such methods.

Claims (26)

1. A nucleic acid molecule which encodes one or more AAV helper functions, said nucleic acid molecule comprising in 5′ to 3′ order:

an AAV rep coding region;

an AAV cap coding region; and

a nucleotide sequence comprising a modified AAV p5 promoter region, such that the modified AAV p5 promoter region no longer functions in transcription initiation.

2. An AAV helper function vector comprising the nucleic acid molecule of claim 1 .

3. The AAV helper function vector of claim 2 , wherein the vector is a plasmid.

4. A method of producing recombinant AAV (rAAV) virions comprising:

(a) introducing an AAV vector into a suitable host cell;

(b) introducing the AAV helper function vector of claim 3 into the host cell;

(c) expressing accessory functions in the host cell; and

(d) culturing the host cell to produce rAAV virions.

5. A host cell comprising the AAV helper function vector of claim 3 .

6. The host cell of claim 5 further comprising accessory function genes.

7. A nucleic acid molecule which encodes one or more AAV helper functions, said nucleic acid molecule comprising in 5′ to 3′ order:

an AAV rep coding region;

an AAV cap coding region; and

a nucleotide sequence comprising a modified AAV p5 promoter region, wherein the modified p5 promoter region lacks an intact TATA box.

8. An AAV helper function vector comprising the nucleic acid molecule of claim 7 .

9. The AAV helper function vector of claim 8 , wherein the vector is a plasmid.

10. A method of producing recombinant AAV (rAAV) virions comprising:

(a) introducing an AAV vector into a suitable host cell;

(b) introducing the AAV helper function vector of claim 9 into the host cell;

(c) expressing accessory functions in the host cell; and

(d) culturing the host cell to produce rAAV virions.

11. A host cell comprising the AAV helper function vector of claim 9 .

12. The host cell of claim 11 further comprising accessory function genes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2007
From: AVIGEN, INC.
To: GENZYME CORPORATION
Reel/Frame 019881/0496 →
Continuity (6)
Continuation 0945008300 · Nov 29, 1999
Continuation 0914327000 · Aug 28, 1998
Continuation In Part 0910770800 · Jun 30, 1998
Continuation In Part 0868864800 · Jul 29, 1996
Continuation In Part 0851079000 · Aug 3, 1995
Related Publication 20020155610A1 · Oct 24, 2002